Some of the newest obesity treatment drugs on the market are known as GLP-1s. These drugs differ from older classes of prescription weight loss medications because they work on underlying metabolic pathways to support sustained, lasting weight loss. The most common GLP-1 drugs include semaglutide and liraglutide, which are sold under the brand names Wegovy, Saxenda, Ozempic, or Mounjaro.